Literature DB >> 33654512

In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.

Adejoke Olukayode Obajuluwa1, Pius Abimbola Okiki1, Tiwalola Madoc Obajuluwa2, Olakunle Bamikole Afolabi3.   

Abstract

INTRODUCTION: the recent zoonotic coronavirus virus outbreak of a novel type (COVID-19) has necessitated the adequate understanding of the evolutionary pathway of zoonotic viruses which adversely affects human populations for therapeutic constructs to combat the pandemic now and in the future.
METHODS: we analyzed conserved domains of the severe acute respiratory coronavirus 2 (SARS-CoV-2) for possible targets of viral entry inhibition in host cells, evolutionary relationship of human coronavirus (229E) and zoonotic coronaviruses with SARS-CoV-2 as well as evolutionary relationship between selected SARS-CoV-2 genomic data.
RESULTS: conserved domains with antagonistic action on host innate antiviral cellular mechanisms in SARS-CoV-2 include nsp 11, nsp 13 etc. Also, multiple sequence alignments of the spike (S) gene protein of selected candidate zoonotic coronaviruses alongside the S gene protein of the SARS-CoV-2 revealed closest evolutionary relationship (95.6%) with pangolin coronaviruses (S) gene. Clades formed between Wuhan SARS-CoV-2 phylogeny data and five others suggests viral entry trajectory while revealing genomic and protein SARS-CoV-2 data from Philippines as early ancestors.
CONCLUSION: phylogeny of SARS-CoV-2 genomic data suggests profiling in diverse populations with and without the outbreak alongside migration history and racial background for mutation tracking and dating of viral subtype divergence which is essential for effective management of present and future zoonotic coronavirus outbreaks. Copyright: Adejoke Olukayode Obajuluwa et al.

Entities:  

Keywords:  SARS-CoV-2; conserved domains; evolution; phylogeny; spike gene; viral entry; zoonotic CoVs

Mesh:

Year:  2020        PMID: 33654512      PMCID: PMC7896521          DOI: 10.11604/pamj.2020.37.285.24663

Source DB:  PubMed          Journal:  Pan Afr Med J


  41 in total

1.  Both Nsp1β and Nsp11 are responsible for differential TNF-α production induced by porcine reproductive and respiratory syndrome virus strains with different pathogenicity in vitro.

Authors:  Qing He; Yan Li; Lei Zhou; Xinna Ge; Xin Guo; Hanchun Yang
Journal:  Virus Res       Date:  2015-02-21       Impact factor: 3.303

Review 2.  Structure, Function, and Evolution of Coronavirus Spike Proteins.

Authors:  Fang Li
Journal:  Annu Rev Virol       Date:  2016-08-25       Impact factor: 10.431

3.  A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.

Authors:  Shuai Xia; Lei Yan; Wei Xu; Anurodh Shankar Agrawal; Abdullah Algaissi; Chien-Te K Tseng; Qian Wang; Lanying Du; Wenjie Tan; Ian A Wilson; Shibo Jiang; Bei Yang; Lu Lu
Journal:  Sci Adv       Date:  2019-04-10       Impact factor: 14.136

Review 4.  Coronavirus envelope protein: current knowledge.

Authors:  Dewald Schoeman; Burtram C Fielding
Journal:  Virol J       Date:  2019-05-27       Impact factor: 4.099

5.  Structural basis for human coronavirus attachment to sialic acid receptors.

Authors:  M Alejandra Tortorici; Alexandra C Walls; Yifei Lang; Chunyan Wang; Zeshi Li; Danielle Koerhuis; Geert-Jan Boons; Berend-Jan Bosch; Félix A Rey; Raoul J de Groot; David Veesler
Journal:  Nat Struct Mol Biol       Date:  2019-06-03       Impact factor: 15.369

Review 6.  Modulation of host cell responses and evasion strategies for porcine reproductive and respiratory syndrome virus.

Authors:  Dongwan Yoo; Cheng Song; Yan Sun; Yijun Du; Oekyung Kim; Hsiao-Ching Liu
Journal:  Virus Res       Date:  2010-07-23       Impact factor: 3.303

Review 7.  Antiviral drugs specific for coronaviruses in preclinical development.

Authors:  Adeyemi O Adedeji; Stefan G Sarafianos
Journal:  Curr Opin Virol       Date:  2014-07-02       Impact factor: 7.090

8.  Refugee and migrant health in the COVID-19 response.

Authors:  Hans Henri P Kluge; Zsuzsanna Jakab; Jozef Bartovic; Veronika D'Anna; Santino Severoni
Journal:  Lancet       Date:  2020-03-31       Impact factor: 79.321

9.  Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.

Authors:  Yadi Zhou; Yuan Hou; Jiayu Shen; Yin Huang; William Martin; Feixiong Cheng
Journal:  Cell Discov       Date:  2020-03-16       Impact factor: 10.849

10.  Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.

Authors:  V Stalin Raj; Huihui Mou; Saskia L Smits; Dick H W Dekkers; Marcel A Müller; Ronald Dijkman; Doreen Muth; Jeroen A A Demmers; Ali Zaki; Ron A M Fouchier; Volker Thiel; Christian Drosten; Peter J M Rottier; Albert D M E Osterhaus; Berend Jan Bosch; Bart L Haagmans
Journal:  Nature       Date:  2013-03-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.